ハイコンテンツスクリーニング市場 – 2030年までの世界予測

出版社 MarketsandMarkets
出版年月 2025年4月

High Content Screening Market – Global Forecast To 2030

ハイコンテンツスクリーニング市場 – 製品とサービス（機器（細胞イメージング、分析システム）、消耗品（試薬とアッセイキット、マイクロプレート）、ソフトウェア）、用途（創薬と開発、毒物学）、エンドユーザー – 2030年までの世界予測
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User – Global Forecast to 2030

The global high content screening market is anticipated to reach USD 2.19 billion in 2030 from USD 1.52 billion in 2025, with a significant CAGR of 7.5%.

世界のハイコンテンツスクリーニング市場は、2025年の15億2,000万米ドルから2030年には21億9,000万米ドルに達し、7.5%という大幅なCAGRで成長すると予想されています。

The market is growing at a significant CAGR owing to the innovations in high-resolution imaging, automation, and artificial intelligence (AI)-powered data analysis, which have significantly enhanced the efficiency and accuracy of HCS workflows. Advanced instruments equipped with high-speed fluorescence microscopy, confocal imaging, and real-time live-cell analysis enable deeper cellular insights, making them essential for drug discovery, toxicity screening, and disease research.

高解像度イメージング、自動化、人工知能 (AI) を活用したデータ分析の革新により、市場は大幅な CAGR で成長しており、HCS ワークフローの効率と精度が大幅に向上しています。高速蛍光顕微鏡、共焦点イメージング、リアルタイムの生細胞分析を備えた高度な機器により、より深い細胞洞察が可能になり、創薬、毒性スクリーニング、疾患研究に不可欠なものとなっています。

ハイコンテンツスクリーニング市場 – 2030年までの世界予測
high-content-screening-market-Ecosystem

The prominent players operating in the high content screening market are Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Corning Incorporated (US), Bio-Rad Laboratories Inc (US), Tecan Trading AG (Switzerland), Evident (Japan), Sysmex Corporation (Japan), Yokogawa Electric Corporation (Japan), Nikon Corporation (Japan),  Sartorius AG (Germany), Promega Corporation (US), Creative Biolabs (US), Enzo Life Sciences (US), Stratedigm Inc. (US), Akoya Biosciences, Inc. (US), Sphere Fluidics (UK), Creative Biostructure (US), Creative Bioarray (US), Cell Signalling Technology (US), Standard Biotools (US), Araceli Biosciences (US), and among others.

The report provides insights on the following pointers:

  • Analysis of key drivers (Advancements in Imaging Technologies, Increased R&D projects, Adoption of High Throughput Screening, implementing organoid models in HCS), restraints (High Equipment and Reagents Costs, Complexity of Data Analysis), opportunities (Integration of AI and ML, Expansion into new applications) and Challenges (Lack of Standardized Protocol) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on upcoming technologies in high content screening, research and development activities, and new product launches in the high content screening market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific, Inc. (US), among others.